Polese, Daniela
Costanzi, Flavia
Bianchi, Paola
Frega, Antonio
Bellati, Filippo
De Marco, Maria Paola
Parisi, Pasquale
Bruni, Oliviero
Caserta, Donatella
Cozza, Giuliana
Article History
Received: 13 December 2022
Accepted: 12 February 2024
First Online: 19 February 2024
Declarations
:
: The need for ethics approval was waived by the IRB of the University Hospital S. Andrea, Sapienza, in Rome in accordance with the Food and Drug Administration (FDA) guideline since the clinical investigation involves no more than minimal risk to the subjects and the subjects will be provided with additional pertinent information after participation [CitationRef removed]. Informed consent was obtained from all the participants in the study. All methods were carried out in in accordance with the relevant guidelines and regulations in the declaration of Helsinki.
: Not applicable.
: The authors declare no competing interests.